FDA Adverse Event Injury Summary report: N

APEX BALLOON CATHETER

MDR report key: 1833651 · Received September 14, 2010

Report

Report Number
2134265-2010-04066
Event Type
Injury
Date Received
September 14, 2010
Date of Event
May 4, 2010
Report Date
August 25, 2010
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
LOX
PMA / PMN Number
P860019
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED.(B)(4).

Description of Event or Problem · 1

(B)(4). IT WAS REPORTED THAT DURING A CORONARY STENTING TREATMENT PROCEDURE, A DISSECTION OCCURRED. THE TARGET LESION BEING TREATED WAS LOCATED IN THE DISTAL LEFT CIRCUMFLEX (LCX). THE LESION WAS 75% STENOSED, 2.75MM IN DIAMETER AND 14MM LONG. THE LESION WAS TREATED WITH PREDILATION AND PLACEMENT OF A 2.50X18/20MM STUDY STENT. DURING THE INDEX, IT WAS NOTED THAT A DISSECTION OCCURRED PROXIMAL TO THE TARGET LESION BY AN UNKNOWN SIZE APEX BALLOON. THE DISSECTION WAS TREATED WITH A 2.75X15MM NON-STUDY DRUG ELUTING STENT. POST DILATION WAS PERFORMED. RESIDUAL STENOSIS WAS 0%. THE PATIENT WAS DISCHARGED 1 DAY LATER ON ASPIRIN AND CLOPIDOGREL. IN (B)(6) 2010, THE PATIENT EXPERIENCED NON-CARDIAC CHEST PAIN. A 30 DAY FOLLOW-UP REVEALED UNSTABLE ANGINA. AN ANGIOGRAPHY WAS PERFORMED BUT NO REVASCULARIZATION WAS REQUIRED. THE EVENT WAS SUCCESSFULLY RESOLVED WITHOUT RESIDUAL EFFECTS. THE PATIENT WAS DISCHARGED 2 DAYS LATER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 APEX BALLOON CATHETER CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS LOX BOSTON SCIENTIFIC - MAPLE GROVE UNK21

Patients

Seq Age Sex Outcome Treatment
1 52 YR Required Intervention